The global biotechnology reagents & kits market size is expected to reach around US$ 987.4 billion by 2030 from US$ 338 billion in 2021 and is expected to grow at an impressive double-digit rate of 11.4% from 2021 to 2030.
The study includes drivers and restraints of this market. The study provides an analysis of the global biotechnology reagents & kits market for the period 2017-2030, wherein 2021 to 2030 is the forecast period and 2020 is considered as the base year.
Various factors such as increased research activities related to stem cell, growing number of biotechnology companies, and rising investments by the biotechnology firms are the significantly driving the growth of the global biotechnology reagents & kits market. The Government of Australia launched a mission in 2019 and announced to invest around US$ 150 million during the period of 9 years, to support the research activities related to stem cell in order to develop medicines for the incurable diseases. The stem cell research results in the extensive consumption of biotechnology reagents.
North America dominated the global biotechnology reagents & kits market, garnering around 40% of the market share in 2020. The various developmental activities such as partnerships, acquisitions, and new product launches undertaken by the local key players, significantly influences the market growth in the region. Further, rising government and corporate investments in the development of various medicines and vaccines is boosting the growth of the biotechnology industry in North America, which led to the biotechnology reagents & kits market growth.
We customize your report according to your research need. REQUEST CUSTOMIZED COPY OF REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/1378
Scope of the Biotechnology Reagents & Kits Market
| Report Coverage | Details |
| Market Size in 2021 | USD 338 Billion |
| Growth Rate From 2021 to 2030 | CAGR of 11.4% |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Base Year | 2021 |
Asia Pacific is estimated to be the most opportunistic market during the forecast period. The rapidly growing biotechnology industry in the Asia Pacific, rising demand for the innovative therapeutics, and growing penetration of numerous biotechnology companies in the region is propelling the growth of the biotechnology reagents & kits market in the region.
The growing demand for the synthetic biology, surging usage of molecular biology, increased investments in the R & D by the biotechnology companies are the primary drivers of the global biotechnology reagents & kits market. Further, the rapid spread of the COVID-19 virus across the globe has resulted in the excess demand for the biotechnology reagents & kits for the purpose of research, COVID-19 testing, and vaccine development, which significantly drives the growth of the market.
The high costs associated with the acquisition of reagents coupled with the stringent government regulations for the clinical trials and approvals of the biotechnology reagents is the significant restraining factor that may hinder the market growth in the forthcoming years.
Based on the technology, the cell culture dominated the market, closely followed by the PCR segment. The cell culture accounted for around 25% of the market share in 2020. The growing demand for the cell culture reagents among the researchers is the major factor behind the segment’s growth. The rising investments by the biotechnology companies is further fueling the segment growth. The PCR segment gained rapid traction in 2020 owing to its increased demand for the COVID-19 testing across the globe.
Based on the kits type, the detection segment dominated the market, accounting for around 23% of the market share in 2020. The surged use of detection kits in various end use applications such as healthcare, agriculture, and industrial processing has significantly fostered the market growth. Moreover, the demand for the detections kids has witnessed a rapid surge in 2020 due to the increased demand for the detection of COVID-19 virus among the global population.
Based on the micro-organisms, the bacteria is estimated to be the most opportunistic segment due to its increasing adoption in the cancer treatment. According to the International Agency for Research on Cancer, around 19.3 million new cancer cases and around 10 million cancer related deaths were reported in the year 2020, across the globe. The rising prevalence of cancer among the global population is expected to drive the growth of this segment, as bacteria can be potentially used as an anti-cancer agent.
Based on the tested parameters, the DNA is expected to be the fastest-growing segment owing to the growing applications of DNA in genetic screening, pharmacogenomics, and drug metabolism. Moreover, the rising demand for the DNA diagnostics is expected to drive the segment growth during the forecast period.
Based on the end use, the healthcare segment dominated the market, garnering a market share of around 52% in 2020. The increased demand for the biotechnology reagents in the various research organizations for clinical diagnostics and clinical trials is spurring the growth of this segment. Moreover, the personalized medicines are gaining momentum in the market, which is expected to further drive the market.
Why should you invest in this report?
If you are aiming to enter the global biotechnology reagents & kits market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for biotechnology reagents & kits are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Some of the prominent players in the global biotechnology reagents & kits market include:
- Abbott Laboratories
- Agilent Technologies
- Danaher Corp.
- Becton Dickinson & Company
- Bio-Rad Laboratories
- GE Healthcare
- Siemens Healthcare
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Waters Corporation
Market Segmentation
By Technology
- PCR
- Cell Culture
- LAMP
- Chromatography
- Sequencing
- Flow Cytometry
- Electrophoresis
- Others
By Kits Type
- Amplifications Kits
- Isolation Kits
- Purification Kits
- Detection Kits
- Others
By Micro-Organisms
- Virus
- Bacteria
- Fungi
- Parasites
By Tested Parameters
- RNA
- DNA
- Enzymes
- Proteins
- Others
By End User
- Healthcare
- Food & Agriculture
- Industrial Processing
- Natural Resource & Environment
- Others
Regional Analysis:
The geographical analysis of the global biotechnology reagents & kits market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.
The North American Market is again segmented into the US, Canada, and Mexico. Coming to the European Market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global biotechnology reagents & kits Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).
Key Questions Answered by the Report:
- What will be the size of the global biotechnology reagents & kits market in 2030?
- What is the expected CAGR for the biotechnology reagents & kits market between 2021 and 2030?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global biotechnology reagents & kits market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Biotechnology Reagents & Kits Market
5.1. COVID-19 Landscape: Biotechnology Reagents & Kits Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Biotechnology Reagents & Kits Market, By Kits Type
8.1. Biotechnology Reagents & Kits Market, by Kits Type, 2021-2030
8.1.1. Amplifications Kits
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Isolation Kits
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Purification Kits
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Detection Kits
8.1.4.1. Market Revenue and Forecast (2019-2030)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Biotechnology Reagents & Kits Market, By Micro-Organisms Type
9.1. Biotechnology Reagents & Kits Market, by Micro-Organisms Type, 2021-2030
9.1.1. Virus
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Bacteria
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Fungi
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Parasites
9.1.4.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Biotechnology Reagents & Kits Market, By Technology Type
10.1. Biotechnology Reagents & Kits Market, by Technology Type, 2021-2030
10.1.1. PCR
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Cell Culture
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. LAMP
10.1.3.1. Market Revenue and Forecast (2019-2030)
10.1.4. Chromatography
10.1.4.1. Market Revenue and Forecast (2019-2030)
10.1.5. Sequencing
10.1.5.1. Market Revenue and Forecast (2019-2030)
10.1.6. Flow Cytometry
10.1.6.1. Market Revenue and Forecast (2019-2030)
10.1.7. Electrophoresis
10.1.7.1. Market Revenue and Forecast (2019-2030)
10.1.8. Others
10.1.8.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Biotechnology Reagents & Kits Market, By Tested Parameters Type
11.1. Biotechnology Reagents & Kits Market, by Tested Parameters Type, 2021-2030
11.1.1. RNA
11.1.1.1. Market Revenue and Forecast (2019-2030)
11.1.2. DNA
11.1.2.1. Market Revenue and Forecast (2019-2030)
11.1.3. Enzymes
11.1.3.1. Market Revenue and Forecast (2019-2030)
11.1.4. Proteins
11.1.4.1. Market Revenue and Forecast (2019-2030)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 12. Global Biotechnology Reagents & Kits Market, By End User Type
12.1. Biotechnology Reagents & Kits Market, by End User, 2021-2030
12.1.1. Healthcare
12.1.1.1. Market Revenue and Forecast (2019-2030)
12.1.2. Food & Agriculture
12.1.2.1. Market Revenue and Forecast (2019-2030)
12.1.3. Industrial Processing
12.1.3.1. Market Revenue and Forecast (2019-2030)
12.1.4. Natural Resource & Environment
12.1.4.1. Market Revenue and Forecast (2019-2030)
12.1.5. Others
12.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 13. Global Biotechnology Reagents & Kits Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Kits (2019-2030)
13.1.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)
13.1.3. Market Revenue and Forecast, by Technology (2019-2030)
13.1.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)
13.1.5. Market Revenue and Forecast, by End User (2019-2030)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Kits (2019-2030)
13.1.6.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)
13.1.6.3. Market Revenue and Forecast, by Technology (2019-2030)
13.1.6.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)
13.1.7. Market Revenue and Forecast, by End User (2019-2030)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Kits (2019-2030)
13.1.8.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)
13.1.8.3. Market Revenue and Forecast, by Technology (2019-2030)
13.1.8.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)
13.1.8.5. Market Revenue and Forecast, by End User (2019-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Kits (2019-2030)
13.2.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)
13.2.3. Market Revenue and Forecast, by Technology (2019-2030)
13.2.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)
13.2.5. Market Revenue and Forecast, by End User (2019-2030)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Kits (2019-2030)
13.2.6.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)
13.2.6.3. Market Revenue and Forecast, by Technology (2019-2030)
13.2.7. Market Revenue and Forecast, by Tested Parameters (2019-2030)
13.2.8. Market Revenue and Forecast, by End User (2019-2030)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Kits (2019-2030)
13.2.9.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)
13.2.9.3. Market Revenue and Forecast, by Technology (2019-2030)
13.2.10. Market Revenue and Forecast, by Tested Parameters (2019-2030)
13.2.11. Market Revenue and Forecast, by End User (2019-2030)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Kits (2019-2030)
13.2.12.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)
13.2.12.3. Market Revenue and Forecast, by Technology (2019-2030)
13.2.12.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)
13.2.13. Market Revenue and Forecast, by End User (2019-2030)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Kits (2019-2030)
13.2.14.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)
13.2.14.3. Market Revenue and Forecast, by Technology (2019-2030)
13.2.14.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)
13.2.15. Market Revenue and Forecast, by End User (2019-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Kits (2019-2030)
13.3.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)
13.3.3. Market Revenue and Forecast, by Technology (2019-2030)
13.3.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)
13.3.5. Market Revenue and Forecast, by End User (2019-2030)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Kits (2019-2030)
13.3.6.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)
13.3.6.3. Market Revenue and Forecast, by Technology (2019-2030)
13.3.6.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)
13.3.7. Market Revenue and Forecast, by End User (2019-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Kits (2019-2030)
13.3.8.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)
13.3.8.3. Market Revenue and Forecast, by Technology (2019-2030)
13.3.8.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)
13.3.9. Market Revenue and Forecast, by End User (2019-2030)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Kits (2019-2030)
13.3.10.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)
13.3.10.3. Market Revenue and Forecast, by Technology (2019-2030)
13.3.10.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)
13.3.10.5. Market Revenue and Forecast, by End User (2019-2030)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Kits (2019-2030)
13.3.11.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)
13.3.11.3. Market Revenue and Forecast, by Technology (2019-2030)
13.3.11.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)
13.3.11.5. Market Revenue and Forecast, by End User (2019-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Kits (2019-2030)
13.4.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)
13.4.3. Market Revenue and Forecast, by Technology (2019-2030)
13.4.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)
13.4.5. Market Revenue and Forecast, by End User (2019-2030)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Kits (2019-2030)
13.4.6.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)
13.4.6.3. Market Revenue and Forecast, by Technology (2019-2030)
13.4.6.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)
13.4.7. Market Revenue and Forecast, by End User (2019-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Kits (2019-2030)
13.4.8.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)
13.4.8.3. Market Revenue and Forecast, by Technology (2019-2030)
13.4.8.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)
13.4.9. Market Revenue and Forecast, by End User (2019-2030)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Kits (2019-2030)
13.4.10.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)
13.4.10.3. Market Revenue and Forecast, by Technology (2019-2030)
13.4.10.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)
13.4.10.5. Market Revenue and Forecast, by End User (2019-2030)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Kits (2019-2030)
13.4.11.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)
13.4.11.3. Market Revenue and Forecast, by Technology (2019-2030)
13.4.11.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)
13.4.11.5. Market Revenue and Forecast, by End User (2019-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Kits (2019-2030)
13.5.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)
13.5.3. Market Revenue and Forecast, by Technology (2019-2030)
13.5.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)
13.5.5. Market Revenue and Forecast, by End User (2019-2030)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Kits (2019-2030)
13.5.6.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)
13.5.6.3. Market Revenue and Forecast, by Technology (2019-2030)
13.5.6.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)
13.5.7. Market Revenue and Forecast, by End User (2019-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Kits (2019-2030)
13.5.8.2. Market Revenue and Forecast, by Micro-Organisms (2019-2030)
13.5.8.3. Market Revenue and Forecast, by Technology (2019-2030)
13.5.8.4. Market Revenue and Forecast, by Tested Parameters (2019-2030)
13.5.8.5. Market Revenue and Forecast, by End User (2019-2030)
Chapter 14. Company Profiles
14.1. Abbott Laboratories
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Agilent Technologies
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Danaher Corp.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Becton Dickinson & Company
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Bio-Rad Laboratories
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. GE Healthcare
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Siemens Healthcare
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Merck KGaA
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Thermo Fisher Scientific Inc.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Waters Corporation
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1378
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
0 Comments